Compare TLX & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLX | COLD |
|---|---|---|
| Founded | 2015 | 1903 |
| Country | Australia | United States |
| Employees | 1184 | 12690 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.3B |
| IPO Year | N/A | 2009 |
| Metric | TLX | COLD |
|---|---|---|
| Price | $9.69 | $15.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 16 |
| Target Price | ★ $21.13 | $14.97 |
| AVG Volume (30 Days) | 103.2K | ★ 3.8M |
| Earning Date | 08-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 7.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,601,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.86 |
| P/E Ratio | $150.33 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.28 | $10.10 |
| 52 Week High | $18.13 | $18.08 |
| Indicator | TLX | COLD |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 66.86 |
| Support Level | $9.46 | $11.93 |
| Resistance Level | $9.92 | $15.38 |
| Average True Range (ATR) | 0.27 | 0.57 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 16.04 | 99.54 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.